+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

From
Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Enhancer Of Zeste Homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Enhancer Of Zeste Homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
RNA Interference Therapy-Competitive landscape, 2023 - Product Thumbnail Image

RNA Interference Therapy-Competitive landscape, 2023

  • Report
  • May 2023
  • 220 Pages
  • Global
From
From
Nasal Drug Delivery Technology Market Report 2023-2033 - Product Thumbnail Image

Nasal Drug Delivery Technology Market Report 2023-2033

  • Report
  • April 2023
  • 397 Pages
  • Global
From
From
From
From
From
From
Lung Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Lung Cancer Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 373 Pages
  • Global
From
Metastatic Colorectal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Colorectal Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 280 Pages
  • Global
From
Loading Indicator